Literature DB >> 18054880

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.

Hans Wildiers1, Ian Kunkler2, Laura Biganzoli3, Jacques Fracheboud4, George Vlastos5, Chantal Bernard-Marty6, Arti Hurria7, Martine Extermann8, Véronique Girre9, Etienne Brain10, Riccardo A Audisio11, Harry Bartelink12, Mary Barton13, Sharon H Giordano14, Hyman Muss15, Matti Aapro16.   

Abstract

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer mortality in women worldwide. Elderly individuals make up a large part of the breast cancer population, and there are important specific considerations for this population. The International Society of Geriatric Oncology created a task force to assess the available evidence on breast cancer in elderly individuals, and to provide evidence-based recommendations for the diagnosis and treatment of breast cancer in such individuals. A review of the published work was done with the results of a search on Medline for English-language articles published between 1990 and 2007 and of abstracts from key international conferences. Recommendations are given on the topics of screening, surgery, radiotherapy, (neo)adjuvant hormone treatment and chemotherapy, and metastatic disease. Since large randomised trials in elderly patients with breast cancer are scarce, there is little level I evidence for the treatment of such patients. The available evidence was reviewed and synthesised to provide consensus recommendations regarding the care of breast cancer in older adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054880     DOI: 10.1016/S1470-2045(07)70378-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  75 in total

1.  Breast Cancer in Special Situations.

Authors:  Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

2.  A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

Authors:  Kenji Hashimoto; Kan Yonemori; Chikako Shimizu; Akihiro Hirakawa; Harukaze Yamamoto; Makiko Ono; Taizo Hirata; Tsutomu Kouno; Kenji Tamura; Noriyuki Katsumata; Masashi Ando; Yasuhiro Fujiwara
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

3.  Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Authors:  Terry S Field; Jaclyn L F Bosco; Marianne N Prout; Heather T Gold; Sarah Cutrona; Pamala A Pawloski; Marianne Ulcickas Yood; Virginia P Quinn; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Am Coll Surg       Date:  2011-10-19       Impact factor: 6.113

4.  Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

Authors:  Esther M de Kruijf; Esther Bastiaannet; Francesca Rubertá; Anton J M de Craen; Peter J K Kuppen; Vincent T H B M Smit; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  Mol Oncol       Date:  2014-04-08       Impact factor: 6.603

5.  Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group.

Authors:  J Barinoff; A Traut; D Bauerschlag; J Bischoff; D Herr; K Lübbe; H-J Lück; N Maass; C Mundhenke; M Schmidt; K Schwedler; M Thill; J Steffen; S Loibl; G von Minckwitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

6.  Significance of age-associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan.

Authors:  Koji Takada; Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Tamami Morisaki; Katsuyuki Takahashi; Masatsune Shibutani; Ryosuke Amano; Tsutomu Takashima; Shuhei Tomita; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

7.  Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Authors:  Diana Crivellari; Kathryn P Gray; Silvia Dellapasqua; Fabio Puglisi; Karin Ribi; Karen N Price; István Láng; Lorenzo Gianni; Simon Spazzapan; Graziella Pinotti; Jean-Marc Lüthi; Richard D Gelber; Meredith M Regan; Marco Colleoni; Monica Castiglione-Gertsch; Rudolf Maibach; Manuela Rabaglio; Alan S Coates; Aron Goldhirsch
Journal:  Breast       Date:  2013-02-28       Impact factor: 4.380

8.  Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer.

Authors:  Z Daher Abdi; S Lavau-Denes; A Prémaud; S Urien; F L Sauvage; J Martin; S Leobon; P Marquet; N Tubiana-Mathieu; A Rousseau
Journal:  Cancer Chemother Pharmacol       Date:  2014-05-07       Impact factor: 3.333

9.  The views of older women towards mammographic screening: a qualitative and quantitative study.

Authors:  K Collins; M Winslow; M W Reed; S J Walters; T Robinson; J Madan; T Green; H Cocker; L Wyld
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

Review 10.  Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.

Authors:  Dae Hyun Kim; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-24       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.